Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction

MLA

J. Luis Guerrero, et al. “Effects of Neuregulin GGF2 (Cimaglermin Alfa) Dose and Treatment Frequency on Left Ventricular Function in Rats Following Myocardial Infarction.” European Journal of Pharmacology, vol. 796, Feb. 2017, pp. 76–89. EBSCOhost, https://doi.org/10.1016/j.ejphar.2016.12.024.

APA

J. Luis Guerrero, Anthony O. Caggiano, Douglas B. Sawyer, Erika L. Troy, Maya Srinivas, Ronald Zolty, Anindita Ganguly, Craig Hackett, Donald Button, Tom J. Parry, Andrea Vecchione, & Jennifer Iaci. (2017). Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction. European Journal of Pharmacology, 796, 76–89. https://doi.org/10.1016/j.ejphar.2016.12.024

Chicago

J. Luis Guerrero, Anthony O. Caggiano, Douglas B. Sawyer, Erika L. Troy, Maya Srinivas, Ronald Zolty, Anindita Ganguly, et al. 2017. “Effects of Neuregulin GGF2 (Cimaglermin Alfa) Dose and Treatment Frequency on Left Ventricular Function in Rats Following Myocardial Infarction.” European Journal of Pharmacology 796 (February): 76–89. doi:10.1016/j.ejphar.2016.12.024.